Journal article · 2021 · Open access

ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition

Xiaodong Wu, Pengpeng Li, Jian Cheng, Qiang Xu, Beiji Lu, Conghui Han, Weiling Huo

Frontiers in Bioengineering and Biotechnology, 9, 608150 · Published 28 January 2021 · DOI 10.3389/fbioe.2021.608150

Open PDFView at the publisherCite this paper

In brief

“ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition” is a 2021 journal article by Xiaodong Wu and 6 co-authors, published in Frontiers in Bioengineering and Biotechnology. OpenAlex counts 31 citations as of 19 November 2026, which puts it in the top 9% of works published in 2021 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Bioengineering and Biotechnology.

Citations
31
Most cited in
2022 (7)
Field-weighted impact
3.31
References
33
Authors
7

Abstract

Objective: Osteoarthritis (OA) is a common subtype of arthritis. To date, treatment of OA focuses primarily on alleviating pain and improving joint function. The lack of a vascular system within synovial joints and the rapid removal of agents due to synovial exchange hinder continuous delivery of OA drugs. However, these obstacles are being addressed by promising nanoscale drugs. Methods: We synthesize and assemble a hydrogen peroxide [H2O2, belongs to the category of active oxygen species (ROS)]-sensitive nanomicelle, which is loaded with the anti-inflammation drug dexamethasone and chondrogenic differentiation factor cartilage-derivedmor-phogeneticprotein-1. The micelle can induce bone marrow mesenchymal stem cells to repair cartilage while inhibiting joint inflammation. Results: The prepared nanoparticles were of uniform size and displayed an obvious core-shell structure. Under H2O2 stimulation, the shell layer could be removed gradually. The drug-loaded micelle effectively inhibited proliferation of activated macrophages, induced macrophage apoptosis with an anti-inflammatory effect, and caused the BMSCs to differentiate into chondrocytes. Conclusion: This work provides an experimental and theoretical basis for further development of a drug-loaded micelle in the healing of osteoarthritis.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wu, X., Li, P., Cheng, J., Xu, Q., Lu, B., Han, C., & Huo, W. (2021). ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition. Frontiers in Bioengineering and Biotechnology, 9, 608150. https://doi.org/10.3389/fbioe.2021.608150

MLA 9

Wu, Xiaodong, et al. “ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition.” Frontiers in Bioengineering and Biotechnology, vol. 9, 2021, p. 608150. https://doi.org/10.3389/fbioe.2021.608150.

Chicago

Wu, Xiaodong, Pengpeng Li, Jian Cheng, Qiang Xu, Beiji Lu, Conghui Han, and Weiling Huo. 2021. “ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition.” Frontiers in Bioengineering and Biotechnology 9: 608150. https://doi.org/10.3389/fbioe.2021.608150.

Harvard

Wu, X. et al. (2021) ‘ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition’, Frontiers in Bioengineering and Biotechnology, 9, p. 608150. doi:10.3389/fbioe.2021.608150.

IEEE

X. Wu et al., “ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition,” Frontiers in Bioengineering and Biotechnology, vol. 9, p. 608150, 2021, doi: 10.3389/fbioe.2021.608150.

BibTeX

@article{wu2021sensitive,
  title     = {{ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition}},
  author    = {Wu, Xiaodong and Li, Pengpeng and Cheng, Jian and Xu, Qiang and Lu, Beiji and Han, Conghui and Huo, Weiling},
  journal   = {Frontiers in Bioengineering and Biotechnology},
  year      = {2021},
  volume    = {9},
  pages     = {608150},
  doi       = {10.3389/fbioe.2021.608150},
  url       = {https://doi.org/10.3389/fbioe.2021.608150}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202155
202277
202355
202455
202577
202622

Its field-weighted citation impact is 3.31: it has been cited 3.31 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms

  • osteoarthritis
  • dexamethasone
  • chondrogenic differentiation
  • bone marrow mesenchymal stem cells
  • cartilage repair
  • anti-inflammatory therapy
  • macrophage apoptosis
  • core-shell nanoparticles

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Wu, X., Li, P., Cheng, J., Xu, Q., Lu, B., Han, C., & Huo, W. (2021). ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition. Frontiers in Bioengineering and Biotechnology, 9, 608150. https://doi.org/10.3389/fbioe.2021.608150

How many times has this paper been cited?

31 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Bioengineering and Biotechnology: sign in and open the PDF from this page.

Who wrote this paper?

Xiaodong Wu, Pengpeng Li, Jian Cheng, Qiang Xu, Beiji Lu, Conghui Han, Weiling Huo.

What is the DOI of this paper?

10.3389/fbioe.2021.608150, permanently at https://doi.org/10.3389/fbioe.2021.608150. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.